Staphylococcus aureus bacteremia among elderly vs younger adult patients: Comparison of clinical features and mortality

Archives of Internal Medicine

Volumn 159, Issue 11, 1999, Pages 1244-1247

  McClelland, R Scott ^a   Fowler Jr , Vance G ^a   Sanders, Linda L ^a   Gottlieb, Geoffrey ^a   Kong, Li Kuo ^a   Sexton, Daniel J ^a   Schmader, Kenneth ^a   Lanclos, Kevin D ^a   Corey, G Ralph ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METICILLIN;

ADULT; AGED; ARTICLE; BACTEREMIA; BLOOD CULTURE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BACTEREMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RISK; STAPHYLOCOCCUS AUREUS; UNITED STATES;

EID: 0033553870     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.11.1244     Document Type: Article

References (29)

1. Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584-602.
2. Cluff LE, Reynolds RC, Page DL, Breckenridge JL. Staphylococcal bacteremia and host resistance. Ann Intern Med. 1968;69:859-873.
3. Jessen O, Rosendal K, Bulow P, Faber V, Eriksen KR. Changing staphylococci and staphylococcal infections. N Engl J Med. 1969;281:627-635.
4. Nolan CM, Beaty HN. Staphylococcus aureus bacteremia. Am J Med. 1976;60: 495-500.
5. Shah M, Watanakunakorn C. Changing patterns of Staphylococcus aureus bacteremia. Am J Med Sci. 1979;278:115-121.
6. Mirimanoff RO, Glauser MP. Endocarditis during Staphylococcus aureussepticemia in a population of non-drug addicts. Arch Intern Med. 1982;142:1311-1313.
7. Finkelstein R, Sobel JD, Nagler A, Merzbach D. Staphylococcus aureus bacteremia and endocarditis: comparison of nosocomial and community-acquired infection. J Med. 1984;15:193-211.
8. Bryan CS, Kirkhart B, Brenner ER. Staphylococcal bacteremia: current patterns in non-university hospitals. South Med J. 1984;77:693-696.
9. Julander I. Unfavourable prognostic factors in Staphylococcus aureus septicemia and endocarditis. Scand J Infect Dis. 1985;17:179-187.
10. Mylotte JM, Beam TR, Allen JC. Staphylococcus aureus bacteremia: a prospective study. South Med J. 1983;76:1131-1135.
11. Mylotte JM, McDermott C, Spooner JA. Prospective study of 114 consecutive episodes of Staphylococcus aureus bacteremia. Rev Infect Dis. 1987;9:891-907.
12. Libman H, Arbeit RD. Complications associated with Staphylococcus aureus bacteremia. Arch Intern Med. 1984;144:541-545.
13. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128-140.
14. Durack DT, Lukes AS, Bright DK. New criteria lor diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96:200-209.
15. Gagliardi JP, Nettles RE, McCarty DE, Sanders LL, Corey GR, Sexton DJ. Native valve infective endocarditis in elderly and younger adult patients: comparison of clinical features and outcomes with use of the Duke criteria and the Duke endocarditis database. Clin Infect Dis. 1998;26:1165-1168.
16. Mortara LA, Bayer AS. Staphylococcus aureus bacteremia and endocarditis. Infect Dis Clin North Am. 1993;7:53-67.
17. Mylotte JM, Aeschlimann JR, Rotella D. Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infect Control Hosp Epidemiol. 1996;17:165-168.
18. Crossley K, Loesch D, Landesman B, Mead K, Chern M, Strate R. An outbreak of infections caused by strains of Staphylococcus aureus resistant to methicillin and aminoglycosides. J Infect Dis. 1979;139:273-279.
19. Peacock JE, Marsik FJ, Wenzel RP. Methicillin-resistant Staphylococcus aureus: introduction and spread within a hospital. Ann Intern Med. 1980;93:536-532.
20. Boyce JM, Landry M, Deetz TR, DuPont HL. Epidemiologic studies of an outbreak of nosocomial methicillin-resistant Staphylococcus aureus. Infect Control. 1981;2:110-116.
21. Grieble HG, Krause SL, Pappas SA, Dicostanzo MB. The prevalence of high-level methicillin resistance in multiply resistant hospital staphylococci. Medicine. 1981; 60:62-69.
22. Sorrel TC, Packham DR, Shanker S, Foldes M, Munro R. Vancomycin therapy for methicillin-resistant Staphylococcus aureus. Ann Intern Med. 1982;97:344-350.
23. Craven DE, Kollisch NR, Hseih CR, Connolly MG, McCabe WR. Vancomycin treatment of bacteremia caused by oxacillin-resistant Staphylococcus aureus: comparison with beta-lactam antibiotic treatment of bacteremia caused by oxacillin-sensitive Staphylococcus aureus. J Infect Dis. 1983;147:137-143.
24. Keane CT, Cafferkey MT. Re-emergence of methicillin-resistant Staphylococcus aureus causing severe infection. J Infect. 1984;9:6-16.
25. Lewis E. Saravolatz LD. Comparison of methicillin-resistant and methicillin-sensitive Staphylococcus aureus bacteremia. Am J Infect Control. 1985;13:109-114.
26. Law MR, Gill ON. Hospital-acquired infection with methicillin-resistant and methicillin-sensitive staphylococci. Epidemiol Infect. 1988;101:623-629.
27. MacManus AT, Mason AD, McManus WF, Pritt BA. What's in a name? Is methicillin-resistant Staphylococcus aureus just another S aureus when treated with vancomycin? Arch Surg. 1989;124:1456-1459.
28. Hershow RC, Khayr WF, Smith NL. A comparison of virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol. 1992;13:587-593.
29. Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ. Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1995;21:1417-1423.